Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Scarlet F. Brockmöller
Observed names:
Scarlet Brockmöller,
Scarlet F Brockmöller
Institution:
University of Cambridge
Observed institutions:
University of Cambridge,
German Breast Group,
Charité – Universitätsmedizin Berlin,
University of California, Davis,
VTT Technical Research Centre of Finland
OpenAlex ID:
A5111748637
Novel Theranostic Opportunities Offered by Characterization of Altered Membrane Lipid Metabolism in Breast Cancer Progression
2011
·
Mika Hilvo
, Carsten Denkert
, et al.
·
Cancer Research
·
575
Comparative metabolomics of estrogen receptor positive and estrogen receptor negative breast cancer: alterations in glutamine and beta-alanine metabolism
2013
·
Jan Budczies
, Scarlet F. Brockmöller
, et al.
·
Journal of Proteomics
·
197
Remodeling of central metabolism in invasive breast cancer compared to normal breast tissue – a GC-TOFMS based metabolomics study
2012
·
Jan Budczies
, Carsten Denkert
, et al.
·
BMC Genomics
·
167
PDF
Metabolomics of human breast cancer: new approaches for tumor typing and biomarker discovery
2012
·
Carsten Denkert
, Elmar Bucher
, et al.
·
Genome Medicine
·
117
PDF
Integration of Metabolomics and Expression of Glycerol-3-phosphate Acyltransferase (GPAM) in Breast Cancer—Link to Patient Survival, Hormone Receptor Status, and Metabolic Profiling
2011
·
Scarlet F. Brockmöller
, Elmar Bucher
, et al.
·
Journal of Proteome Research
·
91
METAtarget - Extracting Key Enzymes of Metabolic Regulation from Highthroughput Metabolomics Data using KEGG REACTION Information.
2010
·
Jan Budczies
, Carsten Denkert
, et al.
·
German Conference on Bioinformatics
·
4
Supplementary Table 3 from Novel Theranostic Opportunities Offered by Characterization of Altered Membrane Lipid Metabolism in Breast Cancer Progression
2023
·
Mika Hilvo
, Carsten Denkert
, et al.
Supplementary Table 1 from Novel Theranostic Opportunities Offered by Characterization of Altered Membrane Lipid Metabolism in Breast Cancer Progression
2023
·
Mika Hilvo
, Carsten Denkert
, et al.
PDF
Supplementary Table 2 from Novel Theranostic Opportunities Offered by Characterization of Altered Membrane Lipid Metabolism in Breast Cancer Progression
2023
·
Mika Hilvo
, Carsten Denkert
, et al.
Supplementary Table 4 from Novel Theranostic Opportunities Offered by Characterization of Altered Membrane Lipid Metabolism in Breast Cancer Progression
2023
·
Mika Hilvo
, Carsten Denkert
, et al.
Supplementary Table 5 from Novel Theranostic Opportunities Offered by Characterization of Altered Membrane Lipid Metabolism in Breast Cancer Progression
2023
·
Mika Hilvo
, Carsten Denkert
, et al.
Supplementary Methods from Novel Theranostic Opportunities Offered by Characterization of Altered Membrane Lipid Metabolism in Breast Cancer Progression
2023
·
Mika Hilvo
, Carsten Denkert
, et al.
Supplementary Figures 1-2 from Novel Theranostic Opportunities Offered by Characterization of Altered Membrane Lipid Metabolism in Breast Cancer Progression
2023
·
Mika Hilvo
, Carsten Denkert
, et al.
PDF
Supplementary Table 6 from Novel Theranostic Opportunities Offered by Characterization of Altered Membrane Lipid Metabolism in Breast Cancer Progression
2023
·
Mika Hilvo
, Carsten Denkert
, et al.
Supplementary Table 7 from Novel Theranostic Opportunities Offered by Characterization of Altered Membrane Lipid Metabolism in Breast Cancer Progression
2023
·
Mika Hilvo
, Carsten Denkert
, et al.
Supplementary Table 9 from Novel Theranostic Opportunities Offered by Characterization of Altered Membrane Lipid Metabolism in Breast Cancer Progression
2023
·
Mika Hilvo
, Carsten Denkert
, et al.
Supplementary Table 8 from Novel Theranostic Opportunities Offered by Characterization of Altered Membrane Lipid Metabolism in Breast Cancer Progression
2023
·
Mika Hilvo
, Carsten Denkert
, et al.
Supplementary Table 2 from Novel Theranostic Opportunities Offered by Characterization of Altered Membrane Lipid Metabolism in Breast Cancer Progression
2023
·
Mika Hilvo
, Carsten Denkert
, et al.
Supplementary Table 1 from Novel Theranostic Opportunities Offered by Characterization of Altered Membrane Lipid Metabolism in Breast Cancer Progression
2023
·
Mika Hilvo
, Carsten Denkert
, et al.
Supplementary Table 5 from Novel Theranostic Opportunities Offered by Characterization of Altered Membrane Lipid Metabolism in Breast Cancer Progression
2023
·
Mika Hilvo
, Carsten Denkert
, et al.
Data from Novel Theranostic Opportunities Offered by Characterization of Altered Membrane Lipid Metabolism in Breast Cancer Progression
2023
·
Mika Hilvo
, Carsten Denkert
, et al.
Data from Novel Theranostic Opportunities Offered by Characterization of Altered Membrane Lipid Metabolism in Breast Cancer Progression
2023
·
Mika Hilvo
, Carsten Denkert
, et al.
Correction to “Integration of Metabolomics and Expression of Glycerol-3-phosphate Acyltransferase (GPAM) in Breast Cancer─Link to Patient Survival, Hormone Receptor Status, and Metabolic Profiling”
2022
·
Scarlet F. Brockmöller
, Elmar Bucher
, et al.
·
Journal of Proteome Research
Show more works
View as search
Works count:
23
Citation count:
1,151
H-index:
5
I10-index:
5
Year
Topic
Type